skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial

André, F. ; Ciruelos, E.M. ; Rubovszky, G. ; Campone, M. ; Loibl, S. ; Rugo, H.S. ; Iwata, H. ; Conte, P. ; Mayer, I.A. ; Kaufman, B. ; Yamashita, T. ; Lu, Y.-S. ; Inoue, K. ; Takahashi, M. ; Pápai, Z. ; Longin, A.-S. ; Mills, D. ; Wilke, C. ; Hirawat, S. ; Juric, D.

Annals of oncology, 2018-10, Vol.29, p.viii709-viii709 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
A phase III study of alpelisib and fulvestrant in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (BC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
A phase III study of alpelisib and fulvestrant in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (BC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase III study of alpelisib and fulvestrant in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (BC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

André, F. ; Kaufman, B. ; Juric, D. ; Ciruelos, E. ; Iwata, H. ; Mayer, I.A. ; Conte, P. ; Rugo, H.S. ; Loibl, S. ; Rubovszky, G. ; Tesch, H. ; Inoue, K. ; Lu, Y.-S. ; Ryvo, L. ; Longin, A.-S. ; Mills, D. ; Wilke, C. ; Germa, C. ; Campone, M.

Annals of oncology, 2016-10, Vol.27, p.vi98-vi98 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
3
137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
Material Type:
Artigo 		Adicionar ao Meu Espaço

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Iwata, H. ; Rubovszky, G. ; Loibl, S. ; Ciruelos, E. ; Campone, M. ; Juric, D. ; Rugo, H. ; Mayer, I. ; Conte, P.F. ; Kaufman, B. ; Inoue, K. ; Tesch, H. ; Li, Y.-S. ; Mingorance, I.D. ; Ryvo, L. ; Iwase, H. ; Longin, A.-S. ; Mills, D. ; Wilke, C. ; Andre, F.

Annals of oncology, 2016-12, Vol.27, p.ix41-ix41 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
Material Type:
Artigo 		Adicionar ao Meu Espaço

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)

Iwata, H. ; Rubovszky, G. ; Loibl, S. ; Ciruelos, E. ; Campone, M. ; Juric, D. ; Rugo, H. ; Mayer, I. ; Conte, P.F. ; Kaufman, B. ; Inoue, K. ; Tesch, H. ; Li, Y-S. ; Mingorance, I.D. ; Ryvo, L. ; Iwase, H. ; Longin, A-S. ; Mills, D. ; Wilke, C. ; André, F.

Annals of oncology, 2016-12, Vol.27 (suppl_9) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial

André, F ; Ciruelos, E M ; Rubovszky, G ; Campone, M ; Loibl, S ; Rugo, H S ; Iwata, H ; Conte, P ; Mayer, I A ; Kaufman, B ; Yamashita, T ; Lu, Y -S ; Inoue, K ; Takahashi, M ; Pápai, Z ; Longin, A-S ; Mills, D ; Wilke, C ; Hirawat, S ; Juric, D

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Assunto 

  1. Hematology  (1)
  2. Oncology  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar

Neste Assunto:

  1. Hematology
  2. Oncology

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.